Integrative Analysis for Elucidating Transcriptomics Landscapes of Glucocorticoid-Induced Osteoporosis
Osteoporosis is the most common bone metabolic disease, characterized by bone mass loss and bone microstructure changes due to unbalanced bone conversion, which increases bone fragility and fracture risk. Glucocorticoids are clinically used to treat a variety of diseases, including inflammation, can...
Main Authors: | Xiaoxia Ying, Xiyun Jin, Pingping Wang, Yuzhu He, Haomiao Zhang, Xiang Ren, Songling Chai, Wenqi Fu, Pengcheng Zhao, Chen Chen, Guowu Ma, Huiying Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.00252/full |
Similar Items
-
Osteoporosis secundaria y Osteoporosis inducida por glucocorticoides (OIG)
by: Elías Forero Illera
Published: (2006-01-01) -
Update on Glucocorticoid Induced Osteoporosis
by: Soo-Kyung Cho, et al.
Published: (2021-06-01) -
Glucocorticoid-induced osteoporosis: 2013 update
by: M. Mazzantini, et al.
Published: (2014-07-01) -
Glucocorticoids induce osteoporosis mediated by glucocorticoid receptor-dependent and -independent pathways
by: Yu Jiang, et al.
Published: (2020-05-01) -
REVIEW OF AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) CLINICAL GUIDELINES FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
by: N. V. Toroptsova
Published: (2018-05-01)